Eisai
4523.T
#2320
Rank
NZ$13.65 B
Marketcap
NZ$48.39
Share price
2.66%
Change (1 day)
-2.98%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.45. an increase over its 2024 EPS that were of NZ$1.63.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025NZ$1.8211.85%
2024NZ$1.63-32.63%
2023NZ$2.425.52%
2022NZ$2.29-74.01%
2021NZ$8.82-66.58%
2020NZ$26.3998.24%
2019NZ$13.3117.01%
2018NZ$11.3837.78%
2017NZ$8.26-27.62%
2016NZ$11.4135.33%
2015NZ$8.43-2.82%
2014NZ$8.67-27.66%
2013NZ$11.99-27.49%
2012NZ$16.54-12.67%
2011NZ$18.9488.08%
2010NZ$10.07-11.06%
2009NZ$11.32-390.15%
2008NZ-$3.90-127.78%
2007NZ$14.0511.78%
2006NZ$12.574.38%
2005NZ$12.047.4%
2004NZ$11.2143.03%
2003NZ$7.8425.09%
2002NZ$6.2752.67%
2001NZ$4.1069.76%
2000NZ$2.42